The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2024 | The patients’ perspective and advocacy in the fight against myeloma
Brian Durie, MD, Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, discusses the importance of patient advocacy in the fight against myeloma, highlighting the role of the International Myeloma Foundation (IMF) in educating and supporting patients while striving for a cure. He stresses the need for improved tools to monitor measurable residual disease (MRD) to better track the disease’s progression and response to treatment. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
